CLINICAL_TRIALS
research
· 2026-02-13
Clinical Trial Update: A Study of AMDX-2011P in Participants With CAA [Phase 2]
Summary
Phase 2 clinical trial evaluating AMDX-2011P in participants with cerebral amyloid angiopathy, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amydis Inc. | Conditions: Cerebral Amyloid Angiopathy | Phase 2 | Status: RECRUITING